Bionic Sight Overview
Latest Deal Type
Early Stage VC
Bionic Sight General Information
Developer of a medical device designed to develop and commercialize the prosthetic treatments for blindness due to retinal degenerative disease. The company's device uses retinal code that can convert visual images into similar patterns of an action potential that the retina normally produces and can do so across a broad range of stimuli including faces, landscapes, and movement, essentially replicating patterns in a code the brain is expecting and can recognize, enabling users to bring prosthetic capabilities up to the level of near-normal image representation.
Want to dig into this profile?
We’ll help you find what you need
Bionic Sight Valuation & Funding
||Raised to Date
|1. Early Stage VC
Bionic Sight Executive Team (2)
|Sheila Nirenberg Ph.D
||Co-Founder & Principal
|William Hauswirth Ph.D